Accomplishments in 2008 in the management of advanced gastroesophageal cancer
Affiliations
- PMID: 20011567
- PMCID: PMC2791384
Item in Clipboard
Accomplishments in 2008 in the management of advanced gastroesophageal cancer
Gastrointest Cancer Res.
2009 Sep.
Abstract
Overview of the Disease Process IncidencePrognosisPrognostic or Predictive FactorsCurrent General Therapy Standards Regional VariationsEvidence for Individual AgentsAccomplishments in 2008 TherapyBiomarkersBasic ScienceWhat Needs to be Done Applications of the AccomplishmentsControversies and DisagreementsSpecial PopulationsFuture Directions Comments on ResearchObstacles to Progress.
Similar articles
-
Accomplishments in 2007 in the management of advanced gastroesophageal cancer.Gastrointest Cancer Res. 2008 May;2(3 Suppl):S47-50. Gastrointest Cancer Res. 2008. PMID: 19352469 Free PMC article.
-
Accomplishments in 2008 in the management of esophageal cancer.Gastrointest Cancer Res. 2009 Sep;3(5 Supplement 2):S53-7. Gastrointest Cancer Res. 2009. PMID: 20011566 Free PMC article.
-
Accomplishments in 2007 in the management of localized pancreatic cancer.Gastrointest Cancer Res. 2008 May;2(3 Suppl):S32-6. Gastrointest Cancer Res. 2008. PMID: 19352466 Free PMC article.
-
Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives.Onco Targets Ther. 2016 Nov 25;9:7235-7245. doi: 10.2147/OTT.S100643. eCollection 2016. Onco Targets Ther. 2016. PMID: 27932891 Free PMC article. Review.
-
Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?Front Oncol. 2020 Jul 21;10:912. doi: 10.3389/fonc.2020.00912. eCollection 2020. Front Oncol. 2020. PMID: 32793461 Free PMC article. Review.
Cited by
-
Geographic difference in safety and efficacy of systemicchemotherapy for advanced gastric or gastroesophagealcarcinoma: a meta-analysis and meta-regression.Gastric Cancer. 2012 Jul;15(3):265-80. doi: 10.1007/s10120-012-0151-8. Epub 2012 May 12. Gastric Cancer. 2012. PMID: 22576708
References
-
- Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96. - PubMed
-
- Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142–146. - PubMed
-
- Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer. 2000;88:921–932. - PubMed
-
- Catalano V, Labianca R, Beretta GD, et al. Gastric cancer. Crit Rev Oncol Hematol. 2005;54:209–241. - PubMed
-
- Patel PR, Yao JC, Hess K, et al. Effect of timing of metastasis/disease recurrence and histologic differentiation on survival of patients with advanced gastric cancer. Cancer. 2007;110:2186–2190. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop.... - PubMed
LinkOut - more resources
Full Text Sources